PRPO – Precipio Inc
Precipio, Inc.PRPO
$22.98Name : Precipio, Inc.
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $40,261,120.00
EPSttm : -0.81
Precipio, Inc.
$22.98
1.84%$0.43Float Short %
0.27
Margin Of Safety %
-22
Put/Call OI Ratio
EPS Next Q Diff
EPS Last/This Y
EPS This/Next Y
Price
22.85
Target Price
19
Analyst Recom
1
Performance Q
12.1
Relative Volume
0.47
Beta
1.12
Ticker: PRPO
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-12-02 | PRPO | 24.85 | N/A | N/A | 0 |
| 2025-12-03 | PRPO | 25.4 | N/A | N/A | 0 |
| 2025-12-04 | PRPO | 24.61 | N/A | N/A | 0 |
| 2025-12-05 | PRPO | 24 | N/A | N/A | 0 |
| 2025-12-08 | PRPO | 24.5 | N/A | N/A | 0 |
| 2025-12-09 | PRPO | 24.02 | N/A | N/A | 0 |
| 2025-12-10 | PRPO | 24.99 | N/A | N/A | 0 |
| 2025-12-11 | PRPO | 24.95 | N/A | N/A | 0 |
| 2025-12-12 | PRPO | 25 | N/A | N/A | 0 |
| 2025-12-15 | PRPO | 24.52 | N/A | N/A | 0 |
| 2025-12-16 | PRPO | 24.02 | N/A | N/A | 0 |
| 2025-12-17 | PRPO | 23.93 | N/A | N/A | 0 |
| 2025-12-18 | PRPO | 23.78 | N/A | N/A | 0 |
| 2025-12-19 | PRPO | 23.56 | N/A | N/A | 0 |
| 2025-12-22 | PRPO | 23.94 | N/A | N/A | 0 |
| 2025-12-23 | PRPO | 23.71 | N/A | N/A | 0 |
| 2025-12-26 | PRPO | 23.76 | N/A | N/A | 0 |
| 2025-12-29 | PRPO | 23.89 | N/A | N/A | 0 |
| 2025-12-30 | PRPO | 23.41 | N/A | N/A | 0 |
| 2025-12-31 | PRPO | 22.99 | N/A | N/A | 0 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-12-02 | PRPO | 24.56 | - | - | - |
| 2025-12-03 | PRPO | 25.48 | - | - | - |
| 2025-12-04 | PRPO | 24.95 | - | - | - |
| 2025-12-05 | PRPO | 24.02 | - | - | - |
| 2025-12-08 | PRPO | 24.86 | - | - | - |
| 2025-12-09 | PRPO | 24.45 | - | - | - |
| 2025-12-10 | PRPO | 24.45 | - | - | - |
| 2025-12-11 | PRPO | 24.98 | - | - | - |
| 2025-12-12 | PRPO | 24.33 | - | - | - |
| 2025-12-15 | PRPO | 24.06 | - | - | - |
| 2025-12-16 | PRPO | 24.06 | - | - | - |
| 2025-12-17 | PRPO | 24.35 | - | - | - |
| 2025-12-18 | PRPO | 23.14 | - | - | - |
| 2025-12-19 | PRPO | 23.79 | - | - | - |
| 2025-12-22 | PRPO | 23.94 | - | - | - |
| 2025-12-23 | PRPO | 23.71 | - | - | - |
| 2025-12-26 | PRPO | 23.80 | - | - | - |
| 2025-12-29 | PRPO | 23.40 | - | - | - |
| 2025-12-30 | PRPO | 23.55 | - | - | - |
| 2025-12-31 | PRPO | 22.85 | - | - | - |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-12-02 | PRPO | -2.43 | 15.89 | 0.09 |
| 2025-12-03 | PRPO | -2.43 | 15.89 | 0.09 |
| 2025-12-04 | PRPO | -2.43 | 15.89 | 0.09 |
| 2025-12-05 | PRPO | -2.43 | 15.89 | 0.09 |
| 2025-12-08 | PRPO | -2.43 | 15.99 | 0.09 |
| 2025-12-09 | PRPO | -2.43 | 15.99 | 0.09 |
| 2025-12-10 | PRPO | -2.43 | 15.99 | 0.49 |
| 2025-12-11 | PRPO | -2.43 | 15.99 | 0.49 |
| 2025-12-12 | PRPO | -2.43 | 15.99 | 0.49 |
| 2025-12-15 | PRPO | -2.43 | 15.64 | 0.48 |
| 2025-12-16 | PRPO | -2.63 | 15.64 | 0.48 |
| 2025-12-17 | PRPO | -2.63 | 15.64 | 0.48 |
| 2025-12-18 | PRPO | -2.63 | 15.64 | 0.48 |
| 2025-12-19 | PRPO | -2.63 | 15.64 | 0.48 |
| 2025-12-22 | PRPO | -2.63 | 15.64 | 0.48 |
| 2025-12-23 | PRPO | -2.63 | 15.64 | 0.48 |
| 2025-12-26 | PRPO | -2.63 | 15.64 | 0.27 |
| 2025-12-29 | PRPO | -2.63 | 15.61 | 0.27 |
| 2025-12-30 | PRPO | -2.63 | 15.61 | 0.27 |
| 2025-12-31 | PRPO | -2.63 | 15.61 | 0.27 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
Avg. EPS Est. Next Quarter
Insider Transactions
-2.63
Institutional Transactions
15.61
Beta
1.12
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
17.88
Quality Score
45
Growth Score
55
Sentiment Score
84
Actual DrawDown %
87.6
Max Drawdown 5-Year %
-95.8
Target Price
19
P/E
Forward P/E
PEG
P/S
1.77
P/B
2.92
P/Free Cash Flow
68.23
EPS
-0.83
Average EPS Est. Cur. Y
EPS Next Y. (Est.)
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-5.5
Relative Volume
0.47
Return on Equity vs Sector %
-36.4
Return on Equity vs Industry %
-19.9
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
Precipio, Inc.Sector: Healthcare
Industry: Diagnostics & Research
Employees: 54
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.
stock quote shares PRPO – Precipio Inc Stock Price stock today
news today PRPO – Precipio Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch PRPO – Precipio Inc yahoo finance google finance
stock history PRPO – Precipio Inc invest stock market
stock prices PRPO premarket after hours
ticker PRPO fair value insiders trading